Plasma IL-6 levels correlate with clinical and ultrasound measures of arthritis in patients with systemic lupus erythematosus
Authors:
- 15 November 2013
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 23 (1) , 46-56
Abstract
The objective of this paper is to elucidate the role of specific cytokines in lupus (SLE) arthritis. Fifty SLE and 40 RA patients had an ultrasound (US) scan of their hand as per standardized protocols. US scores were expressed per joint and as a total ‘US activity’ score, (sum of power Doppler (PD) and grey-scale synovial hypertrophy scores in all joints) and a total erosion score. SLE disease activity was assessed (BILAG and SELENA-SLEDAI). Plasma levels of IL-6, TNF-alpha and BLyS were measured using sandwich ELISA kits (Quantikine kits, R & D). On the basis of the US results SLE patients were divided into three groups: erosive arthritis (n = 20), non-erosive arthritis (n = 18) and those with a normal US scan (n = 12). Across the SLE groups plasma IL-6 levels correlated with CRP (p < 0.001), hand deformity scores (p = 0.005), BILAG musculoskeletal score (p = 0.009), wrist PD score (p = 0.01), the presence of tenosynovitis (p = 0.008) and total US activity score (p < 0.001) (which remained constant when corrected for total BILAG score). Neither TNF-alpha nor BLyS levels correlated with US or clinical measures of lupus arthritis; however, TNF-alpha correlated with total BILAG score (p < 0.001). This is the first study to examine levels of specific cytokines in a cohort of SLE patients stratified in terms of joint disease by US, where the most significant finding is that IL-6 levels correlated both with clinical and US measures of arthritis disease activity.Keywords
This publication has 44 references indexed in Scilit:
- Joint and tendon involvement in systemic lupus erythematosus: an ultrasound study of hands and wrists in 108 patientsRheumatology, 2012
- 2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritisArthritis Care & Research, 2012
- Cytokine disturbances in systemic lupus erythematosusArthritis Research & Therapy, 2011
- EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugsAnnals of the Rheumatic Diseases, 2010
- Numerical scoring for the BILAG-2004 indexRheumatology, 2010
- Tocilizumab in systemic lupus erythematosus: Data on safety, preliminary efficacy, and impact on circulating plasma cells from an open‐label phase I dosage‐escalation studyArthritis & Rheumatism, 2010
- Impact of Treatment with Infliximab on Serum Cytokine Profile of Patients with Rheumatoid and Psoriatic ArthritisAnnals of the New York Academy of Sciences, 2007
- Lupus arthropathy: a case series of patients with rhupusClinical Rheumatology, 2006
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988
- Deforming Non-Erosive Arthritis of the Hand in Systemic Lupus ErythematosusClinical Orthopaedics and Related Research, 1974